Certification of digital courses according to ZPP – Central Prevention Testing Center
Those who develop digital offerings for health promotion or prevention often face the question: How can these be financed through health insurance companies? Many software manufacturers are familiar with the reimbursement options available through DiGA. Much less well...
Switzerland: Reimbursement for digital health applications (DiGA & dGA)
In 2020, Germany became the first country to establish DiGA in regular healthcare. This means that digital health applications can be approved in a structured, transparent process. Once approved, DiGA can then be prescribed by doctors in a similar way to medication....
All insights: Development and approval of software medical devices in 2025
Over the past ten years, we have learned a great deal about the development of software medical devices. We are pleased to share this expertise in our technical articles with (prospective) developers of Software as a Medical Device (SaMD) so that not everyone has to...
MDR Risk Class I vs. IIa: Differences for software medical devices
At the beginning of the development of a software medical device, the central question is: Which risk class applies to my product? Risk classification has serious implications and significantly influences the cost and time frame of product development. In extreme...
DiPA guide: digital applications for care
On December 19, 2019, the Digital Care Act (DVG) made it possiblethat doctors can now prescribe digital health applications (DiGA) to patients in a standardized way for the first time. A counterpart to this has also been created for nursing care: digital care...
Sprechen Sie mit unserem Geschäftsführer Malte Bucksch